If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
971.00    9.00 (0.94%)
Bid:
970.00
Ask:
974.00
Spread: 4.00 (0.412%)
Market Cap: £914.55m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

14 Apr 2025 07:00

RNS Number : 7958E
Polar Capital Holdings PLC
14 April 2025
 

14 April 2025

Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AuM") for the financial year to 31 March 2025.

 

Group AuM (unaudited)

 

Polar Capital reports that as at 31 March 2025 its AuM was £21.4bn compared to £21.9bn at the end of March 2024, a decrease of 2% over the year. During the financial year, we saw net inflows of £0.5bn into the open-ended fund range offset by outflows from segregated mandates and Investment Trust share buy-backs totalling £0.4bn. Including fund closures, net flows were flat and AuM was reduced by £0.5bn arising from market movement and fund performance. 

 

AuM movement in twelve months to 31 March 2025

Open ended

Funds

(£m)

Investment

Trusts

(£m)

Segregated mandates

(£m)

Total

(£m)

AuM at 1 April 2024

15,988

5,088

816

21,892

Net flows

495

(164)

(208)

123

Fund closures1

(111)

-

-

(111)

Market movement

and performance

(378)

(78)

(39)

(495)

Total AuM at 31 March 2025

15,994

4,846

569

21,409

1 Return of funds to investors on closure of the Forager Fund in October 2024 and Financial Opportunities Fund in March 2025.

 

Gavin Rochussen, Chief Executive, commented:

 

"Given significant industry wide net outflows from active equity managers over the period, it is notable that Polar Capital achieved net inflows into its open-ended fund range of £495m (excluding fund closures) and net inflows across all investment offerings of £123m in the year to 31 March 2025.

 

"The start of calendar year 2025 has been difficult for global equity markets with increased volatility and uncertainty introduced by the possibility of a tariff induced global trade war. With investors selling out of risk assets, it is no surprise that during the quarter total AuM decreased by £2.4bn from £23.8bn at the end of December 2024 to £21.4bn at end of March 2025, a 10% decrease, of which net outflows were £0.1bn and market movements and performance made up the remainder.

 

"Over the course of the financial year, a combination of net outflows and fund closures was offset by market and fund performance resulting in our AuM decreasing by 2% to £21.4bn from £21.9bn at the end of March 2024.

 

"During the quarter, we had net inflows of £398m from a range of funds including the Global Absolute Return, International Small Company, Emerging Market Stars, Healthcare Blue chip, Biotechnology, and Artificial Intelligence Funds.

 

"During the quarter, the open-ended Technology Fund saw net outflows of £200m compared to £123m of net outflows in the previous quarter.

 

"The International Small Company Fund, our third US-domiciled mutual fund, which was launched at the end of September 2024, and during a volatile six months for listed equities, has now reached US$90m in assets, and is closing in on the important first milestone of US$100m. As global equity markets broaden out, we believe there will be increasing demand by US investors for international equities which bodes well for the franchise.

 

"While volatile equity markets may impact AuM levels and profitability in the near term, we remain confident that with our diverse range of specialist active fund strategies, we are well-positioned to perform for our clients and shareholders over the long term."

 

Polar Capital plans to announce its results for the financial year to 31 March 2025 on 30 June 2025.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)

Samir Ayub (Chief Financial Officer)

 

+44 (0)20 7227 2700

Numis Securities Limited - Nomad and Joint Broker

Giles Rolls

Charles Farquhar

 

+44 (0)20 7260 1000

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Oliver Jackson

 

+44 (0)20 3597 8680

 

 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEASLDFFXSEFA
Date   Source Headline
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares
19th Nov 20192:53 pmRNSForm 8.3 - Consort Medical Plc
11th Nov 201912:08 pmRNSResignation of Non-Executive Director
30th Oct 201912:00 pmRNSNotice of Results
29th Oct 20195:06 pmRNSHolding(s) in Company
22nd Oct 201912:21 pmRNSForm 8.3 - Wincanton PLC
10th Oct 20197:00 amRNSAuM Update
30th Sep 20194:35 pmRNSPrice Monitoring Extension
13th Sep 20192:59 pmRNSForm 8.3 - OneSavings Bank
10th Sep 20192:39 pmRNSForm 8.3 - OneSavings Bank Plc
3rd Sep 201912:26 pmRNSForm 8.3 - OneSavings Bank Plc
2nd Sep 201911:35 amRNSForm 8.3 - easyHotel Plc
23rd Aug 201911:42 amRNSForm 8.3 - OneSavings Bank Plc
16th Aug 20193:03 pmRNSForm 8.3 - easyHotel PLC
15th Aug 201912:03 pmRNSForm 8.3 - Charter Court Financial Services Group
14th Aug 20193:16 pmRNSForm 8.3 - OneSavings Bank PLC
14th Aug 20193:09 pmRNSForm 8.3 - Charter Court Financial Services Group
13th Aug 20192:43 pmRNSForm 8.3 - Charter Court Financial Services Group
12th Aug 20193:21 pmRNSForm 8.3 - Charter Court Financial Services Group
8th Aug 20192:29 pmRNSForm 8.3 - Charter Court Financial Services Group
8th Aug 20192:27 pmRNSForm 8.3 - OneSavings Bank Plc
7th Aug 20192:32 pmRNSForm 8.3 - OneSavings Bank Plc
7th Aug 20192:31 pmRNSForm 8.3 - Charter Court Financial Services Group
7th Aug 20192:30 pmRNSForm 8.3 - easyHotel PLC
6th Aug 20192:27 pmRNSForm 8.3 - OneSavings Bank PLC
6th Aug 20192:19 pmRNSForm 8.3 - Charter Court Financial Services Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.